Coegin Pharma AB (NGM:COEGIN)

Sweden flag Sweden · Delayed Price · Currency is SEK
4.100
+0.190 (4.86%)
At close: Mar 2, 2026
-2.38%
Market Cap 102.00M
Revenue (ttm) n/a
Net Income (ttm) -20.64M
Shares Out 24.88M
EPS (ttm) -0.80
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 30,093
Average Volume 29,619
Open n/a
Previous Close 3.910
Day's Range n/a
52-Week Range 2.890 - 9.520
Beta 1.20
RSI 50.61
Earnings Date Feb 27, 2026

About Coegin Pharma AB

Coegin Pharma AB, a biotechnology company, engages in developing peptide-based products for hair growth and skin pigmentation in Sweden. The company develops Follicopeptide, a peptide designed to enhance hair growth; and NPP-4, a natural pigmentation peptide 4 works by facilitating the transport of melanin to the skin, mimicking the natural process that occurs during sun exposure or tanning beds. It is also developing FOL026, a drug candidate which is in preclinical trial for the treatment of myocardial infarction; AVX420, a drug candidate whic... [Read more]

Industry Pharmaceutical Preparations
Founded 2005
Employees 3
Stock Exchange Nordic Growth Market
Ticker Symbol COEGIN
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.